grey-arrows-planes
31 July 2013EuropeMatt Smith and Jonathan Wills

Accelerating and decelerating patent prosecution in Europe and the UK

The time it takes for a family of patent applications to progress through patent offices around the world is enormously variable. For many applicants in the life sciences field, delays in the patent application procedure are useful since they delay grant costs, and leave the scope of claims uncrystallised, creating uncertainty for third parties. However, where there is an identifiable product to be pushed to market, there may be a need to get enforceable protection quickly.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
24 March 2026   The drugmaker’s attempt to extend protection for a fast-growing oestrogen-free contraceptive ran into a landmark EU ruling, with the court not persuaded to read it narrowly.
Europe
24 March 2026   The European Patent Office’s Technology Dashboard reveals only a slight increase in medtech filings, and drops in biotech and pharma, against an overall healthy backdrop.
Europe
3 March 2026   After an overwhelmingly positive Supreme Court ruling for companies working in AI, Rachel Free of CMS outlines the necessary practical steps for patent holders—including enforcement of the ‘black box’ tech, the ruling’s influence on the UPC, and how to manage related applications.